Health Care & Life Sciences » Pharmaceuticals | Aeolus Pharmaceuticals Inc.

Aeolus Pharmaceuticals Inc.

Aeolus Pharmaceuticals Inc.
Stock Exchange Other OTC
EPS
$0.04
Market Cap
$182.5 K
Shares Outstanding
152.09 M
Public Float
-

Profile

Address
26361 Crown Valley Parkway
Mission Viejo California 92691
United States
Employees -
Website http://www.aolsrx.com
Updated 07/08/2019
Aeolus Pharmaceuticals, Inc. engages in the business of developing platform of broad-spectrum, catalytic antioxidant compounds that protect healthy tissue from the damaging effects of oxidative stress development of medical countermeasures against biological, chemical and radiological weapons in the U. S. It also develops medical countermeasures for diseases and disorders of the central nervous system, respiratory system, autoimmune system, and oncology.

Financials

View All

David C. Cavalier
Chairman, Chief Financial Officer & Secretary
Amit Kumar
Independent Director